{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0000", "char_start": 0, "char_end": 1200, "pages": [1], "text": "March 2023\nVolume 39 | Number 6\nNew York State to Resume Eligibility Reviews for Medicaid, Child\nHealth Plus and the Essential Plan; Communications Tool Kit\nAvailable to Help Educate Consumers on How to Renew Insurance\nFor the duration of the federal Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE), New\nYork State (NYS) was authorized to protect New Yorkers by pausing annual eligibility reviews and providing\ncontinuous coverage for Medicaid, Child Health Plus (CHP) and the Essential Plan (EP) members/enrollees.\nHowever, on December 29, 2022, the federal Consolidated Appropriations Act updated federal rules to require\nNYS, in partnership with the local Departments of Social Services (LDSS), to once again recertify eligibility\nfor members in these public health programs. For additional information regarding the COVID-19 PHE,\nproviders can refer to the United States (U.S.) Department of Health and Human Services (HHS)\nAdministration for Strategic Preparedness and Response (ASPR) \"Declarations of a Public Health\nEmergency\" web page, located at: https://aspr.hhs.gov/legal/PHE/Pages/default.aspx. For additional\ninformation regarding resumed eligibility reviews, providers"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0001", "char_start": 1050, "char_end": 2250, "pages": [1], "text": "\" web page, located at: https://aspr.hhs.gov/legal/PHE/Pages/default.aspx. For additional\ninformation regarding resumed eligibility reviews, providers can refer to the NY State of Health Important\nChanges to New York Medicaid, Child Health Plus and the Essential Plan web page, located at:\nhttps://info.nystateofhealth.ny.gov/COVID-19-Changes.\nThere are approximately 8 million New Yorkers enrolled in Medicaid, CH and EP who will need to\nrenew their health insurance. It is imperative that members/enrollees are made aware of these\nchanges as they may risk losing their coverage if appropriate actions to renew are not made.\nBeginning in Spring 2023, renewal notices will be sent to members/enrollees based on their enrollment end\ndates. Renewal notices will include the deadline to take action to renew their insurance or risk having a gap\nin coverage. Deadlines will be based on the member/enrollee enrollment end dates and will range from June\n30, 2023, through May 31, 2024. During this time, NY State of Health, the Official Health Plan Marketplace\n(Marketplace), will keep enrollment open to allow consumers who are no longer eligible for Medicaid, CHP or\nEP to stay covered by enrolling in a "}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0002", "char_start": 2100, "char_end": 3300, "pages": [1, 2], "text": "lace\n(Marketplace), will keep enrollment open to allow consumers who are no longer eligible for Medicaid, CHP or\nEP to stay covered by enrolling in a Qualified Health Plan (QHP).\nContinued on Page 3\n***************************************************************************************************************\n\nKathy Hochul\nGovernor\nState of New York\nJames McDonald, M.D., M.P.H.\nCommissioner\nNew York State\nDepartment of Health\nAmir Bassiri\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nNew York State to Resume Eligibility Reviews for Medicaid, Child Health Plus and the Essential Plan;\nCommunications Tool Kit Available to Help Educate Consumers on How to Renew Insurance ............................... Cover\nAll Providers\nAttention Providers: Disclosure of Ownership and Control Information ............................................................................. 3\nPostpartum Period for Pregnant Individuals Increased from 60 Days to 12 Months ......................................................... 4\nOffice of the Medicaid Inspector General to Initiate Compliance Program "}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0003", "char_start": 3150, "char_end": 4350, "pages": [2], "text": "Days to 12 Months ......................................................... 4\nOffice of the Medicaid Inspector General to Initiate Compliance Program Reviews .......................................................... 4\nService Delivery for Managed Long Term Care Enrollees Moving\nfrom Adult Homes to Community Residences in Response to O’Toole v. Cuomo ............................................................ 5\nMedicaid Breast Cancer Surgery Centers .......................................................................................................................... 6\nPharmacy\nAttention Pharmacy Providers: Mifepristone (Mifeprex®) Available to Certified Pharmacies ............................................ 7\nDiabetes Self-Management Training Pharmacy Billing ...................................................................................................... 7\nRisdiplam (Evrysdi®): Medicaid Prior Authorization Drugs Update ................................................................................... 9\nPolicy and Billing\nNusinersen (Spinraza®): Medicaid Practitioner Administered Drugs Update .................................................................. 10\nUpdate t"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0004", "char_start": 4200, "char_end": 5400, "pages": [2, 3], "text": "Nusinersen (Spinraza®): Medicaid Practitioner Administered Drugs Update .................................................................. 10\nUpdate to Medicaid Fee-for-Service Practitioner Administered Drug Policy and Billing Guidance ................................. 11\nApplied Behavior Analysis Services Update .................................................................................................................... 12\nProvider Directory ............................................................................................................................................................. 13\nMarch 2023 New York State Medicaid Update pg. 2\n\nAll Providers\nIn an effort to minimize the number of New Yorkers at risk of being disenrolled, NY State of Health has\ndeveloped the Unwinding from the COVID-19 Public Health Emergency: A Communications Tool Kit to Keep\nNew Yorkers Covered, located at: https://info.nystateofhealth.ny.gov/PHE-tool-kit, which is available in 14\nlanguages and features resources to help educate consumers about these changes. Resources include the\nfollowing:\n• a designed poster, fact sheet and infographic available to print and display;\n• pre-written so"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0005", "char_start": 5250, "char_end": 6450, "pages": [3], "text": "about these changes. Resources include the\nfollowing:\n• a designed poster, fact sheet and infographic available to print and display;\n• pre-written social media posts and images, as well as ad campaign videos that can be shared through\nsocial media account(s);\n• drop-in articles for websites and/or newsletters; and\n• drafted email blast messages to send to your partners and distribution lists.\nNYS Department of Health (DOH) encourages all providers, local districts, stakeholders, and advocates to\naccess and use these communication tools and share with members/enrollees.\nNYS DOH thanks providers for their efforts and assistance in reaching all members/enrollees affected by the\nupcoming changes throughout this renewal process as outreach and cooperative teamwork are crucial during\nthis time. Additionally, NY State of Health appreciates the help of the provider community to ensure New\nYorkers are informed and the health insurance of our most vulnerable populations remains safeguarded.\n***************************************************************************************************************\nAttention Providers:\nDisclosure of Ownership and Control Information\nThis is a reminder tha"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0006", "char_start": 6300, "char_end": 7500, "pages": [3], "text": "**********************************************************\nAttention Providers:\nDisclosure of Ownership and Control Information\nThis is a reminder that in order to receive payments from New York State (NYS) Medicaid, enrolled providers\nare required to inform the NYS Department of Health (DOH) within 15 days of any change in direct or indirect\nownership or control interest in the enrolled provider. Failure to inform the NYS DOH may result in termination\nof enrollment. For purposes of NYS Medicaid regulations, an ownership or control interest means a person\nor corporation that:\n• has an ownership interest totaling five percent or more in a disclosing entity;\n• has an indirect ownership interest equal to five percent or more in a disclosing entity;\n• has a combination of direct and indirect ownership interests equal to five percent or more in a\ndisclosing entity;\n• owns an interest of five percent or more in any mortgage, deed of trust, note, or other obligation\nsecured by the disclosing entity if that interest equals at least five percent of the value of the property\nor assets of the disclosing entity;\n• is an officer or director of a disclosing entity that is organized as a corporat"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0007", "char_start": 7350, "char_end": 8550, "pages": [3], "text": "nt of the value of the property\nor assets of the disclosing entity;\n• is an officer or director of a disclosing entity that is organized as a corporation; or\n• is a partner in a disclosing entity that is organized as a partnership.\nOwnership interest is defined as possession of equity in the capital, stock or profits of a provider. Changes of\nownership or control interest must be reported to the NYS DOH Office of Health Insurance Programs (OHIP)\nby filing an amended, signed ownership and control interest disclosure form. Based upon the information\nsupplied, providers may also be required to complete a new NYS Medicaid provider enrollment application to\nreflect the structural change to their business. Copies of the required disclosure forms can be found on the\neMedNY “Provider Enrollment and Maintenance” web page, located at: https://www.emedny\n.org/info/ProviderEnrollment/index.aspx, by selecting the appropriate provider type and billing status, if\napplicable, then navigating to the “Maintenance Forms” tab of the web page. Individual practitioners can\ncomplete and submit this form electronically on the eMedNY “Provider Enrollment Portal” web page, located\nat: https://www.emedny.org"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0008", "char_start": 8400, "char_end": 9600, "pages": [3, 4], "text": "practitioners can\ncomplete and submit this form electronically on the eMedNY “Provider Enrollment Portal” web page, located\nat: https://www.emedny.org/portal/#web=step1. All other provider types must complete and submit the paper\nform. Providers can also contact the eMedNY Call Center at (800) 343-9000 for assistance.\nMarch 2023 New York State Medicaid Update pg. 3\n\nPostpartum Period for Pregnant Individuals\nIncreased from 60 Days to 12 Months\nState and federal rules defining the postpartum period for consumers enrolled in Medicaid during pregnancy\nhave recently changed. Previously in New York State (NYS), the postpartum period started on the last day of\npregnancy and ended on the last day of the month in which the 60th postpartum day occurred. Under the new\nlaw, the length of the postpartum period is now 12 months. The 12-month postpartum period begins on the\nlast day of the pregnancy and ends on the last day of the 12th month. The change in length of the postpartum\nperiod in state statute ensures all pregnant consumers, who are state residents, will receive the same length\nof coverage at the conclusion of a pregnancy, regardless of their immigration status.\nThe 12-month postpartu"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0009", "char_start": 9450, "char_end": 10650, "pages": [4], "text": "e residents, will receive the same length\nof coverage at the conclusion of a pregnancy, regardless of their immigration status.\nThe 12-month postpartum period is available to all pregnant consumers, regardless of how their pregnancy\nends. However, consumers who have been screened by a provider as presumptively eligible for Medicaid,\nbut who have not been determined eligible for ongoing coverage, are not entitled to this coverage extension.\nThe option to provide 12 months of postpartum coverage will be implemented in all instances where a\nconsumer was eligible and enrolled in Medicaid prior to the end of their pregnancy, including any retroactive\nperiod.\nConsumers will be renewed at the end of the 12-month postpartum period. If at this renewal, they are\ndetermined ineligible for Medicaid, they will continue to be eligible for limited coverage through the Family\nPlanning Extension Program (FPEP) for 24 months calculated from the end of the 60-day postpartum period.\n***************************************************************************************************************\nOffice of the Medicaid Inspector General to Initiate Compliance\nProgram Reviews\nOn December 28, 2022, Title 18"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0010", "char_start": 10500, "char_end": 11700, "pages": [4], "text": "***************************************\nOffice of the Medicaid Inspector General to Initiate Compliance\nProgram Reviews\nOn December 28, 2022, Title 18 of the New York Codes, Rules and Regulations (NYCRR) Part 521, located\nin the Office of the Medicaid Inspector General (OMIG) Summary of Regulation document, at: https://\nomig.ny.gov/media/80411/download?attachment, was adopted, outlining the requirements for effective\ncompliance programs in the Medicaid program. Beginning July 2023, OMIG will initiate compliance program\nreviews to determine if required providers have adopted, implemented, and maintained an effective\ncompliance program as required by 18 NYCRR Part 521, located in the OMIG Summary of Regulation\ndocument, at: https://omig.ny.gov/media/80411/download?attachment. Compliance program reviews will be\nfor a defined period and will confirm the following:\n• the adopted compliance program satisfied the regulatory requirements;\n• the adopted compliance program was implemented and continuously operated for the entire review\nperiod; and\n• the adopted, implemented, and maintained compliance program was effective.\nInitial compliance program reviews will encompass a three-month revie"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0011", "char_start": 11550, "char_end": 12750, "pages": [4, 5], "text": "and\n• the adopted, implemented, and maintained compliance program was effective.\nInitial compliance program reviews will encompass a three-month review period for months on or after April\n1, 2023. Providers are reminded to review the amendments made to 18 NYCRR Part 521, located in the\nOMIG Summary of Regulation document, at: https://omig.ny.gov/media/80411/download?attachment, and\nthe associated guidance available on NYS OMIG website, located at: https://omig.ny.gov/, and make any\nnecessary changes to their compliance programs.\nQuestions and Additional Information:\n• For additional information, providers can refer to the NYS OMIG “Compliance” web page, located at:\nhttps://omig.ny.gov/compliance/compliance.\n• All questions regarding compliance program requirements should be directed to the OMIG Bureau of\nCompliance at compliance@omig.ny.gov.\n***************************************************************************************************************\nMarch 2023 New York State Medicaid Update pg. 4\n\nService Delivery for Managed Long Term Care Enrollees Moving\nfrom Adult Homes to Community Residences in Response to\nO’Toole v. Cuomo\nThis article clarifies the March 8, 2016 New York S"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0012", "char_start": 12600, "char_end": 13800, "pages": [5], "text": "erm Care Enrollees Moving\nfrom Adult Homes to Community Residences in Response to\nO’Toole v. Cuomo\nThis article clarifies the March 8, 2016 New York State (NYS) Administrative Health Home Service Agreement\n(ASA) letter, located at: https://www.health.ny.gov/health_care/medicaid/redesign/mrt90/2016-03-08_state\nwide_asa_letter.htm, outlining the responsibility of Managed Long Term Care (MLTC) Plans to support the\ncommunity transition of individuals residing in adult home facilities. Following a lawsuit in 2013, NYS entered\na settlement agreement with disability advocates and the United States (U.S.) Department of Justice. This\nsettlement agreement affords individuals diagnosed with Serious Mental Illness (SMI) in Adult Homes\n(hereafter referred to as “class members”) the opportunity to move to more integrated community housing\nwith Adult Home Plus (AH+) care coordination and services and supports provided through a MLTC Plan.\nPer the settlement agreement, settlement providers, including MLTC Plans, must educate class members\nabout their right to move to community settings and thoroughly document those conversations. These\nconversations must include a detailed explanation of available"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0013", "char_start": 13650, "char_end": 14850, "pages": [5], "text": " right to move to community settings and thoroughly document those conversations. These\nconversations must include a detailed explanation of available services to support the class transition of the\nmember, including all services they are entitled to receive as part of the MLTC benefit package. MLTC Plans\nmay not state that an MLTC benefit is unavailable without providing a written denial to the class member. All\nefforts to secure said services must be thoroughly documented. MLTC Plans must immediately report any\nchallenges and concerns regarding service delivery for class members to the designated liaison at the NYS\nDepartment of Health (DOH) Bureau of MLTC.\nBackground\nIn 2013, a group of disability advocacy organizations and the U.S. Department of Justice filed a lawsuit\n(O’Toole v. Cuomo, 13-cv-04166) on behalf of persons diagnosed with SMI residing in twenty-three specific\nImpacted Adult Homes in New York City (NYC). The lawsuit alleged that NYS was in violation of Title II of the\nAmericans with Disabilities Act (ADA), 42 U.S.C., §12131 et seq., located at:\nhttps://www.dol.gov/agencies/oasam/centers-offices/civil-rights-center/statutes/title-ii-americans-with-\ndisabilities-act-"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0014", "char_start": 14700, "char_end": 15900, "pages": [5], "text": "§12131 et seq., located at:\nhttps://www.dol.gov/agencies/oasam/centers-offices/civil-rights-center/statutes/title-ii-americans-with-\ndisabilities-act-of-1990, and §504 of the Rehabilitation Act of 1973, 29 U.S.C. §794, located at:\nhttps://www.hhs.gov/civil-rights/for-individuals/disability/laws-guidance/index.html#:~:text=Section%20504%\n20of%20the%20Rehabilitation,assistance%20from%20HHS%3B%2045%20C.F.R. The ADA, as interpreted\nby the Supreme Court in the landmark decision, Olmstead v. L.C., 527 U.S. 581 (1999), mandates that public\nentities must provide disabled persons, including those individuals diagnosed with serious mental illness\n(SMI), with services, programs, and activities in the most integrated setting appropriate to their needs.\nThe 2014 settlement agreement ensures that class members are given every opportunity to move to the most\nintegrated (community) setting possible. To date, due to the collaborative efforts of MLTC Plans, and providers\ncontracted by the NYS Office of Mental Health (OMH) and the NYS DOH, approximately 1,200 class members\nhave moved out of Impacted Adult Homes to more integrated settings.\nQuestions:\n• MLTC policy questions should be directed to the "}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0015", "char_start": 15750, "char_end": 16950, "pages": [5, 6], "text": " 1,200 class members\nhave moved out of Impacted Adult Homes to more integrated settings.\nQuestions:\n• MLTC policy questions should be directed to the NYS DOH Division of Managed Care, Bureau of\nMLTC by telephone at (518) 474-6965.\n• Questions regarding the Disability Advocates Inc. (DAI) Settlement should be directed to the NYS\nDOH Office of Community Transitions by email at CommTran@health.ny.gov or telephone at\n(518) 485-8781.\n• Questions regarding AH+ care coordination can be directed to the AH+ program by email at\nAHPlusProgram@health.ny.gov.\n***************************************************************************************************************\nMarch 2023 New York State Medicaid Update pg. 5\n\nMedicaid Breast Cancer Surgery Centers\nResearch shows that five-year survival rates are higher for patients who have their breast cancer surgery\nperformed at high-volume facilities. A high-volume facility is defined as a hospital or ambulatory surgery center\ndefined averaging 30 or more all-payer surgeries annually over a three-year period. Therefore, it is the policy\nof the New York State (NYS) Department of Health (DOH) that NYS Medicaid members should receive\nmastectomy and lump"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0016", "char_start": 16800, "char_end": 18000, "pages": [6], "text": "eriod. Therefore, it is the policy\nof the New York State (NYS) Department of Health (DOH) that NYS Medicaid members should receive\nmastectomy and lumpectomy procedures associated with a breast cancer diagnosis at a high-volume facility.\nRestricted low-volume facilities will not be reimbursed for breast cancer surgeries provided to NYS Medicaid\nmembers.\nEffective April 1, each year, NYS DOH reviews facilities and releases an updated list that identifies low\nvolume facilities. NYS DOH has completed its annual review of all-payer breast cancer surgical volumes for\n2019 through 2021 using the Statewide Planning and Research Cooperative System (SPARCS) database.\nTwo hundred restricted low-volume hospitals and ambulatory surgery centers throughout NYS were identified.\nThese facilities have been notified of the restriction, effective April 1, 2023. The policy does not restrict the\nability of the facility to provide diagnostic or excisional biopsies and post-surgical care (chemotherapy,\nradiation, reconstruction, etc.) for NYS Medicaid members. For mastectomy and lumpectomy procedures\nrelated to breast cancer, NYS Medicaid members should be directed to high-volume providers in their area.\n"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0017", "char_start": 17850, "char_end": 19050, "pages": [6, 7], "text": "s. For mastectomy and lumpectomy procedures\nrelated to breast cancer, NYS Medicaid members should be directed to high-volume providers in their area.\nFor a list of hospitals and ambulatory surgery centers where NYS Medicaid will not pay for breast cancer\nsurgery, providers can refer to the NYS DOH “Hospitals & Ambulatory Surgery Centers Where Medicaid Will\nNot Pay for Breast Cancer Surgery” web page, located at: https://www.health.ny.gov/health_care/\nmedicaid/quality/surgery/cancer/breast/no_contract.htm. Providers can refer to the NYS DOH “Hospitals &\nAmbulatory Surgery Centers Where Medicaid Will Pay for Breast Cancer Surgery” web page, located at:\nhttps://www.health.ny.gov/health_care/medicaid/quality/surgery/cancer/breast/contract.htm, for the list of\nfacilities approved to provide breast cancer surgery.\nQuestions\nAll questions should be directed to NYS DOH at hcre@health.ny.gov.\n***************************************************************************************************************\nMarch 2023 New York State Medicaid Update pg. 6\n\nPharmacy\nAttention Pharmacy Providers:\nMifepristone (Mifeprex®) Available to Certified Pharmacies\nThe mifepristone (Mifeprex®) Risk Evaluation"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0018", "char_start": 18900, "char_end": 20100, "pages": [6, 7], "text": " pg. 6\n\nPharmacy\nAttention Pharmacy Providers:\nMifepristone (Mifeprex®) Available to Certified Pharmacies\nThe mifepristone (Mifeprex®) Risk Evaluation and Mitigation Strategy (REMS) program was modified by the\nUnited States (U.S.) Food and Drug Administration (FDA) in January 2023, and now, certified pharmacies\nmay dispense mifepristone when the prescriber, patient, and pharmacy comply with the Mifepristone REMS\nprogram. Mifepristone may be billed by New York State (NYS) Medicaid enrolled pharmacy providers that are\ncertified to dispense mifepristone. Additional information regarding the REMS program, the process to be\ncertified, and the dispensing of mifepristone may be found on the U.S. FDA “Information about Mifepristone\nfor Medical Termination of Pregnancy Through Ten Weeks Gestation” web page, located at:\nhttps://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-\nmifepristone-medical-termination-pregnancy-through-ten-weeks-gestation.\nIn addition to general billing rules applicable to all pharmacy claims, the following rules apply when submitting\na pharmacy claim for mifepristone:\n• the pharmacy must be certified* to dispense mifepris"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0019", "char_start": 19950, "char_end": 21150, "pages": [7], "text": "l pharmacy claims, the following rules apply when submitting\na pharmacy claim for mifepristone:\n• the pharmacy must be certified* to dispense mifepristone;\n• the pharmacy may only dispense when the prescription is written by a practitioner certified to prescribe\nmifepristone;\n• the pharmacy must be able to ship mifepristone in a timely manner using a shipping service that\nprovides tracking information;\n• the pharmacy submits a claim for only one course of therapy with no refills; and\n• the drug item is dispensed according to:\nU.S. FDA guidelines;\nNew York State (NYS) laws, rules, and regulations; and\nMedicaid Policy.\n*To certify, a pharmacy must have submitted to the manufacturer a completed Pharmacy Agreement form relevant to the product\ndispensed, either the brand Mifeprex® or the generic mifepristone.\nQuestions:\n• Questions regarding billing should be directed to the eMedNY Call Center at (800) 343 9000.\n• Questions regarding this policy should be directed to the Medicaid Pharmacy Policy Unit at\n‑\nNYRx@health.ny.gov.\n***************************************************************************************************************\nDiabetes Self-Management Training Pharmacy Billing\nT"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0020", "char_start": 21000, "char_end": 22200, "pages": [7, 8], "text": "*************************************************************************************************\nDiabetes Self-Management Training Pharmacy Billing\nThis article is to notify New York State (NYS) Medicaid fee-for-service (FFS) providers and Medicaid Managed\nCare (MMC) Plans that NYS Medicaid program will reimburse for diabetes self-management training (DSMT)\nservices provided by a pharmacist, as described in the Expanded Coverage for Diabetes Self-Management\nTraining article published in the January 2023 issue of the Medicaid Update, located at:\nhttps://www.health.ny.gov/health_care/medicaid/program/update/2023/docs/mu_no2_jan23_pr.pdf.\nFFS Coverage Policy\nDSMT services are reimbursable when provided by a pharmacy that has been accredited or recognized by a\nCenters for Medicare and Medicaid Services (CMS)-approved National Accreditation Organization (NAO).\nThe NYS Medicaid program will reimburse pharmacies for DSMT services provided by an affiliated pharmacist\noperating under the accreditation/recognition of the pharmacy.\nMarch 2023 New York State Medicaid Update pg. 7\n\nFFS Billing Guidance for Pharmacies\nDSMT claims must include a valid International Classification of Diseases (IC"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0021", "char_start": 22050, "char_end": 23250, "pages": [7, 8], "text": "ew York State Medicaid Update pg. 7\n\nFFS Billing Guidance for Pharmacies\nDSMT claims must include a valid International Classification of Diseases (ICD)-10 code for diabetes mellitus.\nDSMT services are billed in single-unit increments with one unit equaling 30 minutes of service. DSMT claims\nshould be submitted using the appropriate Current Procedural Terminology (CPT) code from the table below.\nCPT Code CPT Code Description\nG0108 Diabetes outpatient self-management training services, individual, per 30 minutes.\nG0109 Diabetes outpatient self-management training services, group sessions (two to eight\npatients), per 30 minutes.\nIf billing DSMT for a Medicaid FFS-only NYRx member, the claim should be billed in the National Council for\nPrescription Drug Programs (NCPDP) D.0 claim format. If billing DSMT for a dually eligible\n(Medicare/Medicaid) member, Medicare should be billed first via the medical claim format using either the\n837 Professional or Centers for Medicare and Medicaid Services (CMS) 1500 claim format. A pharmacist\nproviding DSMT to a NYRx member should enter the values in the corresponding NCPDP D.0 fields as\ndescribed below.\nNCPDP D.0 Claim Segment Field Value\n436-E1 (P"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0022", "char_start": 23100, "char_end": 24300, "pages": [8], "text": " DSMT to a NYRx member should enter the values in the corresponding NCPDP D.0 fields as\ndescribed below.\nNCPDP D.0 Claim Segment Field Value\n436-E1 (Product/Service ID Qualifier) Enter the value of CPT code \"07\", which qualifies\nthe code submitted in field 407-D7 (Product/Service\nID) as a procedure code.\n407-D7 (Product/Service ID) Enter the applicable CPT code from the table above.\n442-E7 (Quantity Dispensed) Enter the value “1”.\n405-D5 (Days supply) Enter the value “1”.\n444-E9 (Pharmacist ID) Enter the pharmacist National Provider Identifier\n(NPI) number\n411-DB (Prescriber ID) Leave field blank.\n454-EK (Scheduled Prescription ID Number) Enter serial number “99999999”.\n419-DJ (Prescription Origin Code) Enter origin code “5”.\nThe NCPDP D.0 Companion Guide can be found on the eMedNY “5010/D.0 Transaction Instructions\" web\npage, located at: https://www.emedny.org/HIPAA/5010/transactions/index.aspx.\nMMC\nMMC Coverage Policy\nThe “FFS Coverage Policy” section referenced above also applies to all types of MMC Plans. The April 1,\n2023 pharmacy benefit transition only applies to the NYS Medicaid pharmacy benefits. MMC Plans will\ncontinue to be responsible for providing reimbursement for oth"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0023", "char_start": 24150, "char_end": 25350, "pages": [8, 9], "text": "y benefit transition only applies to the NYS Medicaid pharmacy benefits. MMC Plans will\ncontinue to be responsible for providing reimbursement for other medical benefits, such as DSMT.\nMMC Reimbursement\nThe “FFS Billing Guidance for Pharmacies” section referenced above is specific to NYS Medicaid FFS. For\nNYS Medicaid members enrolled in an MMC Plan, providers should check with the MMC Plan of the enrollee\nfor implementation details, reimbursement fees, and billing instructions. Additionally, MMC Plans will\nreimburse providers no less than the NYS Medicaid FFS rate for DSMT services and must cover the cost of\nDSMT services when rendered by qualified providers who do not participate in the network of the MMC Plan.\nMarch 2023 New York State Medicaid Update pg. 8\n\nQuestions and Additional Information:\n• NYRx FFS claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• NYRx coverage and policy questions should be directed to the NYS Medicaid Pharmacy Policy Unit\nby telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n• MMC general coverage questions should be directed to the OHIP Division of Health Plan Contracting\nand Oversight (DHPCO) by email at co"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0024", "char_start": 25200, "char_end": 26400, "pages": [9], "text": "ealth.ny.gov.\n• MMC general coverage questions should be directed to the OHIP Division of Health Plan Contracting\nand Oversight (DHPCO) by email at covques@health.ny.gov or by telephone at (518) 473-1134.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nMMC Plan of the enrollee.\n• MMC Plan contact information can be found in the eMedNY New York State Medicaid Program\nInformation for All Providers - Managed Care Information document, located at: https://www\n.emedny.org/ProviderManuals/AllProviders/PDFS/Information_for_All_Providers_Managed_Care_Inf\normation.pdf.\n• MMC Plan-specific policies and billing guidance for practitioner administered drugs (PADs) can be\nfound on the NYS DOH \"New York State Medicaid Managed Care (MMC) Pharmacy Benefit\nInformation Center\" website, located at: https://mmcdruginformation.nysdoh.suny.edu/.\n***************************************************************************************************************\nRisdiplam (Evrysdi®):\nMedicaid Prior Authorization Drugs Update\nOn December 15, 2022, the New York State (NYS) Medicaid Drug Utilization Review (DUR) Board\nrecommended changes to the NYRx, the Medicaid "}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0025", "char_start": 26250, "char_end": 27450, "pages": [9], "text": "rugs Update\nOn December 15, 2022, the New York State (NYS) Medicaid Drug Utilization Review (DUR) Board\nrecommended changes to the NYRx, the Medicaid pharmacy program. James McDonald, M.D., M.P.H.,\nCommissioner of the NYS Department of Health (DOH), has approved the DUR Board recommendations\nresulting in changes to the NYRx coverage criteria for the following drugs.\nEffective April 27, 2023, prescribers must ensure patients do not have an advanced disease (e.g., complete\nlimb paralysis or permanent ventilator dependence) before prescribing risdiplam (Evrysdi®).\nPrior Authorization\nFor a full and up-to-date listing of drugs subject to the NYRx Pharmacy Programs and information on NYRx\nprior authorization (PA) programs, prescribers should refer to the NYRx, the Medicaid Pharmacy Program\nPreferred Drug List, located at: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf.\nTo obtain a PA, prescribers must contact the eMedNY clinical call center at (877) 309-9493. The eMedNY\nclinical call center is available 24 hours per day, seven days per week, with pharmacy technicians and\npharmacists who will work with prescribers and/or prescriber agents, to quickly obtain a PA. NYS Medic"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0026", "char_start": 27300, "char_end": 28500, "pages": [9, 10], "text": "en days per week, with pharmacy technicians and\npharmacists who will work with prescribers and/or prescriber agents, to quickly obtain a PA. NYS Medicaid-\nenrolled prescribers can also initiate PA requests using PAXpress®. PAXpress® is a web-based pharmacy\nPA request/response application, accessible through the “PAXpress” button, located on eMedNY homepage,\nat: https://www.emedny.org/index.aspx, under the “eMedNY Tools Center” drop-down button.\nAdditional Information:\n• DUR Board information is available on the NYS DOH \"Drug Utilization Review (DUR)\" web page,\nlocated at: https://www.health.ny.gov/health_care/medicaid/program/dur/index.htm.\n• Additional information is available at the following web pages:\nNYS DOH \"Welcome to NYRx, the Medicaid Pharmacy Program\" web page (https://www.\nhealth.ny.gov/health_care/medicaid/program/pharmacy.htm)\nMagellan Inc. NYRx, the Medicaid Pharmacy Program website (http://newyork.fhsc.com/)\nNYS DOH website (https://www.health.ny.gov/)\neMedNY website (http://www.emedny.org/)\n***************************************************************************************************************\nMarch 2023 New York State Medicaid Update pg. 9\n\nPolicy and Billin"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0027", "char_start": 28350, "char_end": 29550, "pages": [9, 10], "text": "***********************************************************************************\nMarch 2023 New York State Medicaid Update pg. 9\n\nPolicy and Billing\nNusinersen (Spinraza®):\nMedicaid Practitioner Administered Drugs Update\nOn December 15, 2022, the New York State (NYS) Medicaid Drug Utilization Review (DUR) Board\nrecommended changes to the Medicaid pharmacy prior authorization (PA) programs and coverage criteria\nfor practitioner administered drugs (PADs). James McDonald, M.D., M.P.H., Commissioner of the NYS\nDepartment of Health (DOH), has approved the DUR Board recommendations resulting in changes in NYS\nMedicaid coverage criteria for PADs.\nEffective April 27, 2023, providers must ensure patients do not have an advanced disease (e.g., complete\nlimb paralysis or permanent ventilator dependence) before providing nusinersen (Spinraza®), via the medical\nbenefit. Please note: PAD Clinical Criteria Worksheets are available on the NYS DOH “New York State\nMedicaid Fee-for-Service Practitioner Administered Drug Policies and Billing Guidance” web page, located\nat: https://www.health.ny.gov/health_care/medicaid/program/practitioner_administered/ffs_practitioner_\nadminister.htm.\nFee-for-Serv"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0028", "char_start": 29400, "char_end": 30600, "pages": [10], "text": " web page, located\nat: https://www.health.ny.gov/health_care/medicaid/program/practitioner_administered/ffs_practitioner_\nadminister.htm.\nFee-for-Service (FFS) Billing\nDrugs listed in the Physician Manual Fee Schedule, located at: https://www.emedny.org/ProviderManuals/\nPhysician/PDFS/Physician_Manual_Fee_Schedule_Sect3.xls, with a notation of BR (By Report) under the\n“Maximum Fee” column, must be submitted on the Health Care Finance Administration (HCFA) 1500 claim\nform (via paper) with a copy of the itemized invoice as documentation. Additional information can be found in\nthe New York State Medicaid Program Physician Policy Guidelines document, located at:\nhttps://www.emedny.org/ProviderManuals/Physician/PDFS/Physician_Manual_Policy_Guidelines.pdf.\nQuestions and Additional Information:\n• FFS billing and claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• FFS pharmacy and PAD coverage policy questions should be directed to the Medicaid Pharmacy\nPolicy Unit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n• Additional information on the DUR Board is available on the NYS DOH \"Drug Utilization Review\n(DUR)\" web page, located at: https://"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0029", "char_start": 30450, "char_end": 31650, "pages": [10, 11], "text": "Rx@health.ny.gov.\n• Additional information on the DUR Board is available on the NYS DOH \"Drug Utilization Review\n(DUR)\" web page, located at: https://www.health.ny.gov/health_care/medicaid/program/dur/index\n.htm.\n• Additional information is available at the following web pages:\nNYS DOH \"Welcome to NYRx, the Medicaid Pharmacy Program\" web page (https://www.\nhealth.ny.gov/health_care/medicaid/program/pharmacy.htm)\nMagellan Inc. NYRx, the Medicaid Pharmacy Program website (http://newyork.fhsc.com/)\nNYS DOH website (https://www.health.ny.gov/)\neMedNY website (http://www.emedny.org/)\n***************************************************************************************************************\nMarch 2023 New York State Medicaid Update pg. 10\n\nUpdate to Medicaid Fee-for-Service\nPractitioner Administered Drug Policy and Billing Guidance\nAs previously announced in the Updates to Medicaid Fee-for-Service Practitioner Administered Drug Policies\nand Billing Guidance article published in the November 2022 issue of the Medicaid Update, located at:\nhttps://www.health.ny.gov/health_care/medicaid/program/update/2022/docs/mu_no13_nov22_pr.pdf, criteria\nfor administering infliximab, and vedolizumab "}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0030", "char_start": 31500, "char_end": 32700, "pages": [11], "text": "\nhttps://www.health.ny.gov/health_care/medicaid/program/update/2022/docs/mu_no13_nov22_pr.pdf, criteria\nfor administering infliximab, and vedolizumab were effective December 29, 2022. The updated coverage\ncriteria for vedolizumab and infliximab is as follows.\nInfliximab (Remicade®), infliximab-abda (Renflexis®), infliximab-axxq (Avsola™), and\ninfliximab-dyyb (Inflectra®)\nA trial of a conventional agent, disease-modifying anti-rheumatic drug (DMARD) or tumor necrosis factor\ninhibitor (TNFi), Food and Drug Administration (FDA)-approved for self-administration prior to initiation of\ninfliximab, in accordance with FDA package labeling or compendia-supported use.\nVedolizumab (Entyvio®)\nA trial of a conventional agent, DMARD or TNFi, prior to initiation of vedolizumab in accordance with FDA\npackage labeling or compendia-supported use.\nFee-for-Service Billing\nDrugs listed in the Physician Manual Fee Schedule, located at: https://view.officeapps.live.com/op/view\n.aspx?src=https://www.emedny.org/ProviderManuals/Physician/PDFS/Physician_Manual_Fee_Schedule_S\nect3.xls&wdOrigin=BROWSELINK, with a notation of “BR” (By Report) under the “Maximum Fee” column\nmust be submitted on a paper Health Ca"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0031", "char_start": 32550, "char_end": 33750, "pages": [11], "text": "Fee_Schedule_S\nect3.xls&wdOrigin=BROWSELINK, with a notation of “BR” (By Report) under the “Maximum Fee” column\nmust be submitted on a paper Health Care Financing Administration (HCFA) 1500 claim form with a copy of\nthe itemized invoice as documentation. Additional information can be found in the New York State Medicaid\nProgram – Physician Policy Guidelines, located at: https://www.emedny.org/ProviderManuals/Physician/\nPDFS/Physician_Manual_Policy_Guidelines.pdf.\nQuestions and Additional Information:\n• Fee-for-service (FFS) billing and claim questions should be directed to the eMedNY Call Center at\n(800) 343-9000.\n• Practitioner administered drug Clinical Criteria Worksheets can be found on the New York State (NYS)\nDepartment of Health (DOH) \"New York State Medicaid Fee-for-Service Practitioner Administered\nDrug Policies and Billing Guidance\" web page, located at: https://www.health.ny.gov/health_care\n/medicaid/program/practitioner_administered/ffs_practitioner_administer.htm.\n• FFS pharmacy and practitioner administered drug coverage policy questions should be directed to the\nMedicaid Pharmacy Policy Unit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n• Addition"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0032", "char_start": 33600, "char_end": 34800, "pages": [11, 12], "text": " policy questions should be directed to the\nMedicaid Pharmacy Policy Unit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n• Additional information on the Drug Utilization Review (DUR) Board is available on the NYS DOH \"Drug\nUtilization Review (DUR)\" web page, located at: https://www.health.ny.gov/health_care/medicaid\n/program/dur/index.htm.\n• Additional information is also available at the following websites:\nNYS DOH \"Welcome to NYRx, the Medicaid Pharmacy Program\" web page (https://www.\nhealth.ny.gov/health_care/medicaid/program/pharmacy.htm)\nNYS DOH website (https://www.health.ny.gov/)\neMedNY website (https://www.emedny.org/)\n***************************************************************************************************************\nMarch 2023 New York State Medicaid Update pg. 11\n\nApplied Behavior Analysis Services Update\nEffective April 1, 2023, the New York State (NYS) Medicaid fee-for-service (FFS) program has added the\nfollowing Current Procedural Terminology (CPT) codes to the Applied Behavior Analysis (ABA) Fee Schedule:\nCPT Code CPT Code Description\n97154 Group adaptive behavior treatment by protocol, administered by technician under the\ndirection of "}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0033", "char_start": 34650, "char_end": 35850, "pages": [12], "text": "A) Fee Schedule:\nCPT Code CPT Code Description\n97154 Group adaptive behavior treatment by protocol, administered by technician under the\ndirection of a physician or other qualified health care professional, face-to-face with two or\nmore patients, each 15 minutes.\n97157 Multiple-family group adaptive behavior treatment guidance, administered by physician\nor other qualified health care professional (without the patient present), face-to-face with\nmultiple sets of guardians/caregivers, each 15 minutes.\nThe ABA Fee Schedule can be found on the eMedNY “Applied Behavior Analysis (ABA)” web page, located\nat: https://www.emedny.org/ProviderManuals/ABA/index.aspx. The New York State Medicaid Fee-For-\nService Program – Licensed Behavior Analysts & Certified Behavior Analyst Assistants Policy Manual for\nProviding Applied Behavior Analysis Services, located at: https://www.emedny.org/Provider\nManuals/ABA/PDFS/ABA_Policy.pdf, has been updated.\nQuestions and Additional Information:\n• FFS coverage and policy questions should be directed to the Office of Health Insurance Programs\n(OHIP) Division of Program Development and Management (DPDM) by telephone at (518) 473-2160\nor by email FFSMedicaidPoli"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0034", "char_start": 35700, "char_end": 36900, "pages": [12, 13], "text": "e of Health Insurance Programs\n(OHIP) Division of Program Development and Management (DPDM) by telephone at (518) 473-2160\nor by email FFSMedicaidPolicy@health.ny.gov.\n• FFS billing/claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• Medicaid Manage Care (MMC) enrollment, reimbursement, billing and/or documentation requirement\nquestions should be directed to the specific MMC Plan of the enrollee. MMC Plan contact information\ncan be found in the eMedNY New York State Medicaid Program Information for All Providers -\nManaged Care Information document, located at: https://www.emedny.org/ProviderManuals/\nAllProviders/PDFS/Information_for_All_Providers_Managed_Care_Information.pdf.\n***************************************************************************************************************\nMarch 2023 New York State Medicaid Update pg. 12\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud, waste, or abuse complaints/allegations, please call 1-877-87FRAUD, (877) 873-7283,\nor visit the Office of Medicaid Inspector General (OMIG) web site at: www.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Trainin"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0035", "char_start": 36750, "char_end": 37950, "pages": [13], "text": " the Office of Medicaid Inspector General (OMIG) web site at: www.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at: www.emedny.org.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nPlease enroll online for a provider seminar at: https://www.emedny.org/training/index.aspx. For individual\ntraining requests, please call (800) 343-9000.\nBeneficiary Eligibility:\nPlease call the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following web sites:\n• DOH Prescriber Education Program page:\nhttps://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-educationprog.\n• Prescriber Education Program in partnership with SUNY: http://nypep.nysdoh.suny.edu/.\neMedNY\nFor a number of services, including: change of address, upda"}
{"doc_id": "mu_no6_mar23_pr.pdf", "chunk_id": "mu_no6_mar23_pr.pdf::0036", "char_start": 37800, "char_end": 38407, "pages": [13], "text": "scriber Education Program in partnership with SUNY: http://nypep.nysdoh.suny.edu/.\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit the eMedNY Provider\nEnrollment page at: https://www.emedny.org/info/ProviderEnrollment/index.aspx, and choose the\nappropriate link based on provider type.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nMarch 2023 New York State Medicaid Update pg. 13"}
